Scarica l'app Stockscreener
289.15
0.53%
-1.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$290.70
Aprire:
$286.56
Volume 24 ore:
1.94M
Relative Volume:
1.39
Capitalizzazione di mercato:
$56.06B
Reddito:
$316.65B
Utile/perdita netta:
$1.90B
Rapporto P/E:
29.75
EPS:
9.72
Flusso di cassa netto:
$1.14B
1 W Prestazione:
-1.09%
1M Prestazione:
-2.05%
6M Prestazione:
+18.70%
1 anno Prestazione:
+21.61%
Intervallo 1D:
$278.20
$290.26
Intervallo di 1 settimana:
$273.43
$292.76
Portata 52W:
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Confronta COR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
289.15 | 56.36B | 316.65B | 1.90B | 1.14B | 9.72 |
|
MCK
Mckesson Corporation
|
659.01 | 83.68B | 377.60B | 3.16B | 5.67B | 25.08 |
|
CAH
Cardinal Health Inc
|
146.30 | 37.63B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
67.50 | 8.02B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.86 | 689.96M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Investors Still Waiting For A Pull Back In Cencora, Inc. (NYSE:COR) - 富途牛牛
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap (NYSE:COR) - Seeking Alpha
Cencora Lifts Earnings Outlook After Strong Q3 Performance - MSN
Cencora & The Lash Group Settle Data Breach Litigation for $40 Million - The HIPAA Journal
Cencora (COR) Shares Jump 1.95% as Trading Volume Surges to $530M Ranking 184th in Market Activity - AInvest
3 Reasons Growth Investors Will Love Cencora (COR) - Yahoo Finance
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - simplywall.st
Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend - ca.finance.yahoo.com
Published on: 2025-08-10 00:34:30 - metal.it
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Cencora Rises 2.42% as Trading Volume Slumps to 313th Market Rank - AInvest
Cencora Q3: Growing Specialty Drug Distributions; Initiate At Buy (NYSE:COR) - Seeking Alpha
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - MSN
Cencora, Inc. Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora: Fiscal Q3 Earnings Snapshot - New Haven Register
Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend - simplywall.st
Cencora’s Earnings Call: Strong Growth Amid Challenges - TipRanks
Cencora Earnings: Solid Results Illustrate Healthy Demand and Stable Outlook; Shares Fairly Valued - Morningstar
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook - AOL.com
Cencora Benefits From Strong GLP-1 Sales, Healthy Utilization Trends, and Growing Specialty Assets - Morningstar
Cencora, Inc. SEC 10-Q Report - TradingView
Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth - MSN
Cencora weakness after earnings ‘overdone,’ says Leerink - TipRanks
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised - The Globe and Mail
Earnings call transcript: Cencora Inc. beats Q3 2025 expectations, stock dips - Investing.com Nigeria
Transcript : Cencora, Inc., Q3 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised By Investing.com - Investing.com South Africa
Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised - Investing.com
Cencora, Inc. Exceeds Expectations with Strong Fiscal Q3 EarningsNews and Statistics - IndexBox
Cencora Inc (COR) Q3 2025 Earnings: EPS of $3.52 Beats Estimates, Revenue Hits $80.7 Billion - GuruFocus
Cencora beats Q3 expectations, raises full-year earnings outlook By Investing.com - Investing.com Australia
Cencora, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
Cencora beats Q3 expectations, raises full-year earnings outlook - Investing.com
Cencora Inc earnings beat by $0.16, revenue topped estimates - Investing.com South Africa
Cencora’s (NYSE:COR) Q2 Sales Top Estimates - Yahoo Finance
Cencora Earnings Soar Past Estimates as Healthcare Giant Boosts 2025 Profit Outlook - Stock Titan
Stock Analysis | Cencora OutlookNavigating a Weak Technical Profile with Strong Fundamentals - AInvest
Cencora's $440M Volume Surge Ranks 281st Amid 0.44% Drop as Liquidity-Driven Gains Outpace Market - AInvest
Mallinckrodt Names Leslie Donato to Board of Directors - BioSpace
Cencora & The Lash Group reach $40M settlement in data breach class action - Claim Depot
What institutional investors are buying Cencora Inc. stockBuild wealth steadily with proven investment techniques - Jammu Links News
What catalysts could drive Cencora Inc. stock higher in 2025Maximize returns with disciplined trading - Jammu Links News
Should I hold or sell Cencora Inc. stock in 2025Invest in stocks with strong fundamentals - Jammu Links News
How volatile is Cencora Inc. stock compared to the marketInvest confidently with professional market insights - Jammu Links News
What are the latest earnings results for Cencora Inc.Capitalize on market shifts before others do - Jammu Links News
Cencora Inc. Stock Analysis and ForecastOutperformance with explosive growth - Jammu Links News
What makes Cencora Inc. stock price move sharplyHigh-impact investment strategies - Jammu Links News
How does Cencora Inc. compare to its industry peersCapitalize on market trends with confidence - Jammu Links News
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
7.21%
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):